These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1534664)

  • 41. The hemodynamic effects of long-term ACE inhibition with fosinopril in patients with heart failure. Fosinopril Hemodynamics Study Group.
    Sharma S; Deitchman D; Eni JS; Gelperin K; Ilgenfritz JP; Blumenthal M
    Am J Ther; 1999 Jul; 6(4):181-9. PubMed ID: 11329095
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fosinopril: a new generation of angiotensin-converting enzyme inhibitors.
    Weber MA
    J Cardiovasc Pharmacol; 1992; 20 Suppl 10():S7-12. PubMed ID: 1283429
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Comparison of the antihypertensive activity of fosinopril and irbesartan].
    Angulo E; Robles NR; Grois J; Barquero A; Pérez Miranda M
    An Med Interna; 2002 Nov; 19(11):571-5. PubMed ID: 12522893
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The angiotensin converting enzyme inhibitors fosinopril and enalapril differ in their central nervous effects in humans.
    Derad I; Otterbein A; Mölle M; Pietrowsky R; Born J; Fehm HL
    J Hypertens; 1996 Nov; 14(11):1309-15. PubMed ID: 8934359
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effects of calcium antagonist, angiotensin-converting enzyme inhibitors and beta-blocker on hemodynamic and sympathetic nerve responses to exercise in essential hypertension].
    Fujiwara S; Arita M; Ueno Y; Shiotani M; Nakatsu C; Nakamura Y; Hano T; Nishio I; Masuyama Y
    J Cardiol; 1991; 21(1):115-24. PubMed ID: 1687786
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Disparate cardiovascular response to stress tests during isradipine and fosinopril therapy.
    Grossman E; Messerli FH; Oren S; Soria F; Schmieder RE
    Am J Cardiol; 1993 Sep; 72(7):574-9. PubMed ID: 8362773
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative evaluation of the effect of afterload- and preload-reducing drugs on diastolic cardiac function in hypertensive patients.
    Schneeweiss A; Marmor AT
    Cardiology; 1991; 78(1):39-44. PubMed ID: 1827042
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Post acute myocardial infarction: the Fosinopril in Acute Myocardial Infarction Study (FAMIS).
    Borghi C; Marino P; Zardini P; Magnani B; Collatina S; Ambrosioni E
    Am J Hypertens; 1997 Oct; 10(10 Pt 2):247S-254S. PubMed ID: 9366281
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Effectiveness and tolerance of fosinopril in the treatment of arterial hypertension of mild and medium severity].
    Rosolová H; Cech J; Sefrna F
    Vnitr Lek; 2001 Dec; 47(12):834-9. PubMed ID: 11826546
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Efficacy of combined use of fosinopril and propranolol in acute myocardial infarction].
    Agaev MM; Azizov VA
    Kardiologiia; 2003; 43(2):29-34. PubMed ID: 12891269
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of the angiotensin II receptor blockers telmisartan versus valsartan on the circadian variation of blood pressure: impact on the early morning period.
    White WB; Lacourciere Y; Davidai G
    Am J Hypertens; 2004 Apr; 17(4):347-53. PubMed ID: 15062889
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomised trial.
    Solomon SD; Janardhanan R; Verma A; Bourgoun M; Daley WL; Purkayastha D; Lacourcière Y; Hippler SE; Fields H; Naqvi TZ; Mulvagh SL; Arnold JM; Thomas JD; Zile MR; Aurigemma GP;
    Lancet; 2007 Jun; 369(9579):2079-87. PubMed ID: 17586303
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of fosinopril on the blood pressure and lipid profile of patients undergoing heart transplantation.
    Almenar L; Osa A; Palencia M; Flores A; Sánchez E
    J Heart Lung Transplant; 1997 Apr; 16(4):454-9. PubMed ID: 9154957
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Apoptosis, myocardial fibrosis and angiotensin II in the left ventricle of hypertensive rats treated with fosinopril or losartan.
    Yu G; Liang X; Xie X; Yang T; Sun M; Zhao S
    Chin Med J (Engl); 2002 Sep; 115(9):1287-91. PubMed ID: 12411096
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
    Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME;
    Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Discordant responses to two classes of drugs acting on the renin-angiotensin system.
    Sever PS; Chang CL
    J Renin Angiotensin Aldosterone Syst; 2001 Mar; 2(1):25-30. PubMed ID: 11881062
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Metabolic effects of long-term angiotensin-converting enzyme inhibition with fosinopril in patients with essential hypertension: relationship to angiotensin-converting enzyme inhibition.
    Reneland R; Andersson PE; Haenni A; Lithell H
    Eur J Clin Pharmacol; 1994; 46(5):431-6. PubMed ID: 7957538
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The acute and chronic effects of cilazapril on cardiac function in hypertensive patients.
    Schneeweiss A; Marmor A
    Kardiol Pol; 1990; 33(8):13-6. PubMed ID: 2150081
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reversal of peripheral microvascular dysfunction during long-term treatment with the angiotensin-converting enzyme inhibitor fosinopril in congestive heart failure.
    Galatius S; Wroblewski H; Sørensen V; Haunsø S; Nørgaard T; Kastrup J
    J Card Fail; 1999 Mar; 5(1):17-24. PubMed ID: 10194656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.